About Us

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

The Bristol Myers Squibb head office for Belgium and Luxemburg is in Braine L'Alleud, Belgium. Bristol Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.

Each day, our employees around the world work together for patients—it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, and fibrosis. Through our Research & Development organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.

As global citizens, we work sustainably and responsibly and seek to give back. Through the Bristol Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.

BMS Worldwide

Update 2024

Chief Executive Officer:
Princeton, New Jersey, USA
NYSE Listing:
Net Global Sales:
$46.0 billion in 2021
R&D Investment:
$11.14 billion which included the discovery and development of new medicines for patients
Principal Locations:

BMS in Belgium and Luxembourg

Update 2024

General Manager:
Sally Ann McNab
Local Headquarters:
Parc de l’Alliance
Avenue de Finlande 4
1420 Braine-l’Alleud
Key Therapeutic Areas: